A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil), 2 FDA Approved Pulmonary Hypertension Medications

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Northwestern University
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01305252
First received: November 2, 2010
Last updated: May 21, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)